HomePPGN • SWX
add
Polypeptide Group AG
Previous close
CHF 25.75
Day range
CHF 24.90 - CHF 25.35
Year range
CHF 13.22 - CHF 32.70
Market cap
832.45M CHF
Avg Volume
65.59K
P/E ratio
-
Dividend yield
-
Primary exchange
SWX
In the news
TipRanks
2 hours ago
PolyPeptide expands EUR 200 million credit line to back growth and capacity plans
2.31%
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 111.12M | 10.15% |
Operating expense | 14.65M | 38.81% |
Net income | 2.68M | 165.66% |
Net profit margin | 2.42 | 159.75% |
Earnings per share | — | — |
EBITDA | 16.83M | 118.49% |
Effective tax rate | 51.17% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 74.59M | 9.24% |
Total assets | 825.96M | 9.17% |
Total liabilities | 485.36M | 21.54% |
Total equity | 340.60M | — |
Shares outstanding | 33.01M | — |
Price to book | 2.50 | — |
Return on assets | 3.36% | — |
Return on capital | 5.76% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 2.68M | 165.66% |
Cash from operations | 13.93M | -68.68% |
Cash from investing | -30.45M | -3.58% |
Cash from financing | 13.31M | 304.36% |
Net change in cash | -1.05M | -110.64% |
Free cash flow | -13.11M | 42.12% |
About
Founded
1952
Headquarters
Website
Employees
1,395
